From a fundamental viewpoint, the company has a value in line with the industry as its enterprise value ratios shows.
Nonetheless, recently, EPS estimates for the two coming years have been revised upward by analysts. This positive fact opens the way for a better evaluation of the security by investors.

Technically, in daily data, even if moving averages are still in a downtrend, a positive reaction in the USD 85.7 area should stop this trend and allow a technical rebound towards USD 94.55. Moreover, technical indicators show a significant oversold condition which strengthens this bullish scenario.

Therefore, the proximity of the USD 83.7 support is an opportunity to take a long position in Edwards Lifesciences. The first goal is a return in the USD 94.55 resistance. A stop loss order can be placed under the support currently tested.